Your email has been successfully added to our mailing list.

×
0.00378787878787871 -0.0530303030303031 -0.0530303030303031 -0.0530303030303031 -0.0530303030303031 0.0160984848484848 0.0151515151515152 -0.0189393939393939
Stock impact report

Hancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in Colombia

Hancock Jaffe Laboratories, Inc. (HJLI) 
Company Research Source: GlobeNewswire
IRVINE, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has completed and submitted its application to INVIMA (the Colombian equivalent of the US FDA) for approval of its first-in-human trial for the VenoValve®.  INVIMA is the last regulatory approval that HJLI needs in order to begin its first-in-human testing in Colombia. HJLI expects to receive a response from INVIMA within 60 days. In order to facilitate the INVIMA application process and its first-in-human trial in Columbia, HJLI has hired Bioaccess™, a U.S. based contact research organization (CRO) that specializes in obtaining regulatory approval and in facilitating clinical trials in Colombia. Bioaccess will continue to provide CRO assistance to HJLI throughout its trial in Colombia. “The Colombian first-in-human study is a monumental milestone for our company and we Show less Read more
Impact Snapshot
Event Time:
HJLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for HJLI alerts
Opt-in for
HJLI alerts

from News Quantified
Opt-in for
HJLI alerts

from News Quantified